Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

31.65 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Aug 5, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	18,277
Open	31.65
Bid (Size)	31.41 (100)
Ask (Size)	31.58 (100)
Prev. Close	31.65
Today's Range	31.65 - 31.65
52wk Range	13.74 - 65.30
Shares Outstanding	191,922,517
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic ↗

August 05, 2026

Hims & Hers Health shares have rallied despite an FTC lawsuit over data sharing and billing practices, as weight-loss drug partnerships and Wall Street's cautious Hold rating shape the stock's outlook...

Via MarketBeat

Kaplan Fox is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm

August 04, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Performance

YTD	-5.3%	-5.3%
1 Month	-17.3%	-17.3%
3 Month	+17.7%	+17.7%
6 Month	+29.7%	+29.7%
1 Year	-43.0%	-43.0%

More News

Is Hims & Hers Health Stock in Trouble? ↗

August 03, 2026

Via The Motley Fool

NYSE: HIMS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

August 03, 2026

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

Bearish Pressure Is Building Around These 3 Stocks ↗

August 03, 2026

Via MarketBeat

1 Russell 2000 Stock with Exciting Potential and 2 We Ignore

August 03, 2026

Via StockStory

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Regarding an Investigation Into Possible Securities Law Violations

July 31, 2026

Via NewMediaWire

2 Growth Stocks with Explosive Upside and 1 That Underwhelm

July 31, 2026

Via StockStory

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with SBS Law

July 30, 2026

From Schall, Brown & Schwartz LLP

Via Business Wire

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

July 30, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

July 30, 2026

From Law Offices of Howard G. Smith

Via Business Wire

2 Unprofitable Stocks for Long-Term Investors and 1 We Ignore

July 30, 2026

Via StockStory

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

July 29, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Hims & Hers Responds to FTC Lawsuit

July 29, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

July 24, 2026

Via StockStory

Why Is Hims & Hers Health Stock Surging on Thursday? ↗

July 23, 2026

Via Benzinga

1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds

July 22, 2026

Via StockStory

Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗

July 21, 2026

Via Benzinga

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

July 17, 2026

From Hims & Hers

Via Business Wire

3 Reasons HIMS Has Explosive Upside Potential

July 17, 2026

Via StockStory

Lowey Dannenberg, P.C. Investigates Hims & Hers Health, Inc. for Alleged Tracking of User Data

July 15, 2026

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

July 13, 2026

From Hims & Hers

Via Business Wire

1 Stock Under $50 with Exciting Potential and 2 Facing Challenges

July 13, 2026

Via StockStory

Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 06, 2026

Via The Motley Fool

As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner ↗

July 06, 2026

Via MarketBeat

Frequently Asked Questions

Is Hims & Hers Health, Inc. Class A Common Stock publicly traded?

Yes, Hims & Hers Health, Inc. Class A Common Stock is publicly traded.

What exchange does Hims & Hers Health, Inc. Class A Common Stock trade on?

Hims & Hers Health, Inc. Class A Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Hims & Hers Health, Inc. Class A Common Stock?

The ticker symbol for Hims & Hers Health, Inc. Class A Common Stock is HIMS on the New York Stock Exchange

What is the current price of Hims & Hers Health, Inc. Class A Common Stock?

The current price of Hims & Hers Health, Inc. Class A Common Stock is 31.65

When was Hims & Hers Health, Inc. Class A Common Stock last traded?

The last trade of Hims & Hers Health, Inc. Class A Common Stock was at 08/05/26 07:00 PM ET

What is the market capitalization of Hims & Hers Health, Inc. Class A Common Stock?

The market capitalization of Hims & Hers Health, Inc. Class A Common Stock is 6.07B

How many shares of Hims & Hers Health, Inc. Class A Common Stock are outstanding?

Hims & Hers Health, Inc. Class A Common Stock has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.